The systemic exposure is simply too low to drive a meaningful pharmacokinetic interaction
There is no published degradation kinetics study for GHK-Cu specifically that I can cite with confidence
Taking tirzepatide early or late occasionally is fine, but consistently irregular dosing leads to fluctuating drug levels, inconsistent appetite suppression, and suboptimal results
The fate of taspoglutide, a weekly GLP-1 receptor agonist, versus twice-daily exenatide for type 2 diabetes: the T-emerge 2 trial
Green tea polyphenols and dietary fibre protect against kidney damage in rats with diabetic nephropathy
Statistical analysis Statistical analysis was performed with the use of GraphPad 9 (GraphPad Software, Inc., CA, USA)